Skip to content

Postprandial Effects of a High Potassium Meal

Postprandial Physiological Effects of a High Potassium Meal in Patients With Hypertension

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02959931
Enrollment
33
Registered
2016-11-09
Start date
2013-06-30
Completion date
2014-12-31
Last updated
2020-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Keywords

Dietary Potassium

Brief summary

The investigators aim to evaluate the acute effects of potassium supplementation achieved by ingestion of potassium rich food, on vascular health.

Detailed description

Many studies have shown that an increase in potassium through the diet or through potassium pills helps to lower blood pressure. Also, the amount of oral potassium taken can improve how well the participants blood vessels work. These studies have focused on potassium given in the form of a pill. The investigators are interested in the effect of potassium consumed through food sources and how it will effect arterial health and blood pressure. The world health organization (WHO) recommends a K⁺ intake of at least 3510 mg/day from food for adults, excluding those with impaired K⁺ excretion. In this study the investigators aim to provide approximately 75% (approximately 2000 mg) of the total daily recommended intake for potassium in one meal. The investigators do not know whether dietary potassium (not pill form) will acutely improve the arterial health and if it will cause a decrease in blood pressure. The investigators hypothesis to see an improvement in vascular function following a high potassium meal compared to a low potassium meal.

Interventions

OTHERHigh Potassium Meal

Breakfast meal that provides \ 2400 mg of dietary potassium. Meals are isocaloric.

OTHERLow Potassium Meal

Breakfast meal that provides \ 540 mg of potassium. Meals are isocaloric.

Sponsors

Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* 18-80 years * Normal sinus rhythm * A diagnosis of hypertension on medical therapy with an ambulatory systolic blood pressure \<160 mmHg and diastolic blood pressure \<90 mmHg, or a diagnosis of stable coronary artery disease

Exclusion criteria

* Recent hospital admission due to an cardiovascular events * Serum K+ concentration \>5.0 mmol/L * Current smoking * Women who are pregnant * Diabetic patients - patients receiving insulin therapy * Glomerular filtration rate \< 90mls/min/1.73m2 * On loop diuretic therapy * Food allergies and/or intolerance to meal items

Design outcomes

Primary

MeasureTime frameDescription
Change in Flow Mediated DilatationFlow Mediated Dilatation will be assessed over 2 clinic visits, at 3 times points with in each visit; pre-prandial and post-prandial at 60 min and 120 minFlow Mediated Dilatation is a method used to measure endothelial-dependent regulation of conduit artery tone(Joannides R, 1995).

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026